Regulation

Share:

Why do veterinary medicines require regulation, and who is responsible for overseeing this process?

Veterinary medicines must be regulated to protect both animal and public health, as well as to ensure the safety of the food we eat. Unregulated use could lead to harmful side effects, ineffective treatment, or the development of resistance. Regulations also help to ensure that medicines are effective, safe, and, in the case of food-producing species, safe for humans who might consume animal-derived products. The responsibility and oversight typically lie with national regulatory authorities, such as the Veterinary Medicines Directorate in the United Kingdom, or the European Medicines Agency in Europe. These organisations develop standards and frameworks for the evaluation, approval and monitoring of veterinary medicines.

How are veterinary medicines approved for use, and what safety assessments are performed?

Before a veterinary medicine can be approved for use, it is evaluated for its safety, quality and efficacy. Manufacturers are required to submit comprehensive data detailing the medicine’s composition, production methods and results from laboratory and clinical studies. These studies are designed to demonstrate that the medicine is not only effective for its intended purpose, but also safe for the target species, for people who may handle or administer the product, and for the wider environment. Regulatory authorities carefully review all submitted evidence, ensuring that the product meets high standards for quality control and does not pose undue risks. Only after passing through these thorough assessments is a veterinary medicine granted authorisation for use.

How are veterinary medicines monitored after approval to ensure ongoing safety?

After approval, veterinary medicines continue to be closely monitored. This ongoing process, known as pharmacovigilance, involves gathering and evaluating reports of adverse events from veterinary professionals, animal owners, manufacturers and distributors. Regulatory agencies keep records of any side effects or safety issues and may decide to restrict, suspend or withdraw a product from the market if new concerns arise. In addition, products are periodically reviewed to ensure that they remain safe and effective according to current scientific standards.

How are veterinary medicines classified and distributed?

In the UK, veterinary medicines are divided into categories that regulate how they can be supplied to ensure safe and responsible use. Prescription-only medicines (POM-V) require a clinical assessment and can only be prescribed and supplied by a veterinary surgeon. There is also a category called POM-VPS, where medicines can be prescribed and supplied not only by veterinary surgeons but also by pharmacists and Suitably Qualified Persons (SQPs), most commonly through veterinary practices, pharmacies and authorised retailers.

For non-food animals, NFA-VPS medicines can be supplied without a prescription by vets, pharmacists or SQPs, providing more flexibility for pet owners. The broadest category AVM-GSL, includes medicines safe enough to be sold directly in pet shops, supermarkets and online outlets, without the need for professional advice. This classification system means medicines that require professional oversight are carefully controlled, while lower-risk medicines are widely accessible. For further details, the Veterinary Medicines Directorate (VMD) website offers comprehensive guidance on these categories and their route of distribution.

What regulations govern the sales, distribution, prescription and dispensing of veterinary medicines?

There are strict regulations regarding how veterinary medicines are sold, distributed, prescribed and dispensed. Prescription-only medicines (POM-V) can only be prescribed by qualified veterinary surgeons and are typically dispensed by registered veterinary practices or accredited pharmacies. Strict protocols are in place regarding the storage and handling of these medicines, requiring appropriate facilities and robust record-keeping to ensure safety and traceability. The Veterinary Medicines Directorate oversees compliance, conducting regular inspections of premises involved in the supply chain. For medicines administered to food-producing animals, additional requirements ensure that withdrawal periods and maximum residue limits are adhered to, safeguarding consumer health. These comprehensive regulations help prevent misuse, counterfeiting and contamination, ensuring that all veterinary medicines used in the UK meet high standards of quality and safety.

What is a withdrawal period for livestock products, and why is it important for food safety?

The withdrawal period is the mandatory span of time that must elapse after an animal receives its last treatment before any products derived from it, such as meat, milk or eggs, can enter the human supply chain. This period allows the animal’s body to break down and eliminate any medicinal residues, ensuring that they are below legal safety thresholds when the product reaches consumers. Adhering to withdrawal periods is critical for food safety and public health, as consuming products containing antibiotic residues could lead to allergic reactions or contribute to antibiotic resistance. These timeframes are carefully determined based on scientific study and are enforced through regulation and inspection.

How do residue surveillance, MRLs and withdrawal periods ensure the safety of animal-derived foods?

Residues surveillance is a critical process that involves systematically testing animal-derived foods for traces of veterinary medicines. By regularly monitoring products like meat, milk and eggs, authorities can ensure that any detected residues remain within safe, legal limits.

Central to this system are Maximum Residue Limits (MRLs), which set the highest permissible levels of veterinary drug residues in food. Alongside MRLs, withdrawal periods are established to indicate how long must pass after an animal receives medication before its products can enter the food chain. Together, these measures work to protect public health, maintain consumer confidence, and uphold rigorous safety standards.

Further Reading

For further information, please see the following sources:

• Veterinary Medicines Directorate (VMD) Information Hub (Available at: VMD Information Hub – GOV.UK)
• Veterinary Medicines Directorate (VMD) Veterinary Medicines Legislation (Available at: Veterinary medicines legislation – GOV.UK)
• European Medicines Agency (EMA) Veterinary Medicinal Products Regulation (Available at: Veterinary Medicinal Products Regulation | European Medicines Agency (EMA))
• Royal College of Veterinary Surgeons (RCVS) Veterinary Medicines Supporting Guidance for Veterinary Surgeons (Available at: 4. Veterinary medicines – Professionals)